All Stories

  1. Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
  2. Effects of 3-month high-intensity interval training vs. moderate endurance training and 4-month follow-up on fat metabolism, cardiorespiratory function and mitochondrial respiration in obese adults
  3. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease
  4. Association of Hypomorphic P2X7 Receptor Genotype With Age
  5. Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease
  6. Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation
  7. Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
  8. The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
  9. Correlation of the endoscopic findings for small and large bowels in pediatric patients with established Crohn’s disease
  10. Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1
  11. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
  12. Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer’s Disease
  13. Gene expression profiling of gluteal adipose tissue after prolonged bedrest
  14. Gene expression of FNDC5 and related genes in gluteal subcutaneous adipose tissue and plasma irisin levels after acute inactivity
  15. TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
  16. Effects of 14 days of bed rest and following physical training on metabolic cost, mechanical work, and efficiency during walking in older and young healthy males
  17. Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia
  18. Loss of maximal explosive power of lower limbs after 2 weeks of disuse and incomplete recovery after retraining in older adults
  19. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation
  20. Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer’s Disease
  21. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women
  22. Anabolic resistance assessed by oral stable isotope ingestion following bed rest in young and older adult volunteers: Relationships with changes in muscle mass
  23. Abstracts from the 2017 Italian-German Purine Club Meeting
  24. Dietary composition may influence Nesfatin-1 plasma concentration in humans
  25. Effect of 14 days of experimental horizontal bed rest on circulating levels of irisin
  26. Gene expression profiling of gluteal adipose tissue after prolonged bedrest
  27. Gene expression regional differences in human subcutaneous adipose tissue
  28. Obstructive Sleep Apnea syndrome in obese patients: Effects on metabolic and cardiovascular profile and impact of 6 months of behavioural therapy
  29. Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells
  30. CCT AND BDNF DURING BED REST: PROTECTING AGING INDIVIDUALS FROM ACUTE STRESS
  31. Gene expression regional differences in human subcutaneous adipose tissue
  32. Computerized cognitive training and brain derived neurotrophic factor during bed rest: mechanisms to protect individual during acute stress
  33. Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
  34. Gene expression profiling of gluteal adipose tissue after prolonged bedrest
  35. Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases
  36. Bilateral strio-pallido-dentate calcinosis (Fahr’s disease): report of seven cases and revision of literature
  37. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
  38. Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
  39. Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals
  40. Age-related differences in plasma BDNF levels after prolonged bed rest
  41. Greater loss in muscle mass and function but smaller metabolic alterations in older compared with younger men following 2 wk of bed rest and recovery
  42. Exceptional Exercise Capacity in an 80-Year-Old Breast Cancer Survivor and Long-Term Sprint Athlete
  43. serum paraoxonase in alzheimer and MCI
  44. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
  45. Serum levels of hydroperoxides and multimorbidity among older patients with mild cognitive impairment or late-onset Alzheimer’s disease
  46. PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
  47. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)
  48. Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
  49. Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
  50. Brain-Derived Neurotrophic Factor Plasma Levels: Relationship With Dementia and Diabetes in the Elderly Population
  51. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia
  52. Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
  53. Is a liberal transfusion strategy better than a symptomatic strategy in patients with cardiovascular disease undergoing surgical hip fracture repair?
  54. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study
  55. PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome
  56. Session information
  57. Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals
  58. Reduced factor VII and factor VIII levels and prolonged thrombin-generation times during a healthy diet in middle-aged women with mild to moderate cardiovascular disease risk
  59. Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia
  60. MODERATE ALCOHOL INTAKE AND HEMOSTATIC AND INFLAMMATORY MARKERS IN MIDDLE-AGED WOMEN: A CONTROLLED STUDY
  61. PO5-136 ASSOCIATION BETWEEN ACE GENE INSERTION/DELETION (ACE I/D) POLYMORPHISM, PPAR-GAMMA PRO12ALA (PRO12ALA) POLYMORPHISM AND ATPIII METABOLIC SYNDROME COMPONENTS IN A COHORT OF OBESE SUBJECTS
  62. PO20-595 SHORT TERM EFFECT OF FOUR DIFFERENT MACRONUTRIENT ORAL LOADS ON METABOLIC PROFILE AND FLOW MEDIATED VASODILATATION IN HEALTHY YOUNG MEN
  63. Transient massive hyperlipidaemia in a type 2 diabetic subject
  64. Acute Vascular Events and Electrolytes Variations in Elderly Patients
  65. We-W33:3 Adiposity is an important determinant of chronic low-grade inflammation and is associated with carotid artery intima-media thickness
  66. Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes
  67. TRACE ELEMENTS AND COGNITIVE IMPAIRMENT: AN ELDERLY COHORT STUDY
  68. Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport
  69. Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up
  70. Abstracts of the IDF Congress in Paris 2003
  71. Metabolic Profile in Patients with Benign Prostate Hyperplasia or Prostate Cancer and Normal Glucose Tolerance
  72. Atorvastatin improves metabolic control and endothelial function in Type 2 diabetic patients: A placebo-controlled study
  73. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: A randomized, placebo-controlled clinical trial
  74. Abstracts of the 37th Annual Meeting of the EASD Glasgow, United Kingdom, 9–13 September 2001
  75. Role of diabetes in influencing leptin concentration in elderly overweight patients
  76. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women
  77. A Defect in Glycogen Synthesis Characterizes Insulin Resistance in Hypertensive Patients With Type 2 Diabetes
  78. Benzodiazepines with different half-life and falling in a hospitalized population
  79. The relationship of plasma glucose and electrocardiographic parameters in elderly women with different degrees of glucose tolerance
  80. Simvastatin, transdermal patch and oral estrogen-progestin preparation in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial
  81. Effect of Native and Oxidized Low-Density Lipoprotein on Endothelial Nitric Oxide and Superoxide Production
  82. Factors influencing plasma homocysteine levels in type 2 diabetes
  83. C41 Factors influencing plasma homocysteine as marker of CHD in type 2 diabetes
  84. MTHFR mutation and carotid wall thickness in aging non diabetic women